Loading...

Trees Corporation

CANN•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.03
$0.004(14.16%)

Trees Corporation (CANN) Stock Overview

Explore Trees Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.5/100

Key Financials

Market Cap3.3M
P/E Ratio-0.48
EPS (TTM)$-0.05
ROE4.15%
Fundamental Analysis

AI Price Forecasts

1 Week$0.02
1 Month$0.00
3 Months$0.01
1 Year Target$0.00

CANN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Trees Corporation (CANN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.48 and a market capitalization of 3.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;